HealthMore in Health→
Macrophage Cell Therapy Shows Long-Term Promise in Advanced Cirrhosis
Key Takeaways
- A MATCH clinical trial compared macrophage cell therapy with standard care in advanced cirrhosis.
- After four years, 70% of treated patients were alive without transplant versus 40% in the control group.
- Researchers reported no serious side effects in treated patients.
DE
DT Editorial Team··via medicalxpress.com